Ultrasonographic and morphological studies of the postmenopausal endometrium using unopposed estrogen replacement therapy with regular pause: a prospective preliminary study

dc.contributor.authorPatriarca, M. T.
dc.contributor.authorLima, G. R. de
dc.contributor.authorStavale, J. N.
dc.contributor.authorGoncalves, Wagner Jose [UNIFESP]
dc.contributor.authorFreitas, V
dc.contributor.authorSoares, J. M.
dc.contributor.authorSimoes, M. J.
dc.contributor.authorBaracat, E. C.
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T12:31:28Z
dc.date.available2016-01-24T12:31:28Z
dc.date.issued2001-09-01
dc.description.abstractHormone replacement therapy with progestogen is known to have severe side effects or complications in certain patients. Objective: the goal of this study is to evaluate the safety and efficacy of an alternative treatment regimen with a mensal pause using both transvaginal sonography (TVS) and endometrial biopsy to follow patients. Methods: A total of 30 postmenopausal women were treated with unopposed estrogen for 21 days each month followed by a regular pause of 9-10 days, and were studied prospectively for 18 months. the TVS measurements of endometrial thickness and biopsy of the endometrium were done on the 21 st day of treatment and the 7th day of the pause at 6-month intervals throughout the study. Results: There was a significant decrease of proliferative activity at all three time points during the study (6, 12 and 18 months) when tested on the 7th pause day (PD7). the percentage of patients with hyperplasia without nuclear atypia and endometrial thickness greater than or equal to8 mm was 32% at 6 months, but decreased to 22 and 19% at 12 and IS months, respectively. All cases of hyperplasia regressed after the hormonal pause throughout the treatment period. Conclusions: This study presents an alternative treatment regimen for select patients having side effects or complications from progestogen administration; however, studies evaluating the safety and efficacy of this regimen over longer time periods are necessary. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.en
dc.description.affiliationUniversidade Federal de São Paulo, Dept Gynecol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Pathol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Histol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Gynecol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Pathol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Histol, Escola Paulista Med, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent119-123
dc.identifierhttp://dx.doi.org/10.1016/S0301-2115(01)00286-X
dc.identifier.citationEuropean Journal of Obstetrics Gynecology and Reproductive Biology. Clare: Elsevier Sci Ireland Ltd, v. 98, n. 1, p. 119-123, 2001.
dc.identifier.doi10.1016/S0301-2115(01)00286-X
dc.identifier.issn0301-2115
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/26620
dc.identifier.wosWOS:000170851500022
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofEuropean Journal of Obstetrics Gynecology and Reproductive Biology
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.subjectmenopauseen
dc.subjectunopposed estrogen therapyen
dc.subjecttransvaginal sonographyen
dc.subjectendometrial thicknessen
dc.subjectendometrial morphologyen
dc.titleUltrasonographic and morphological studies of the postmenopausal endometrium using unopposed estrogen replacement therapy with regular pause: a prospective preliminary studyen
dc.typeinfo:eu-repo/semantics/article
Arquivos